Ernexa Therapeutics ERNAW
NASDAQ ERNAW
$0.06 +0.01 (+25.27%)
As of: Sep 4, 2026 · 3:55 PM EDT

Ernexa Therapeutics (ERNAW) Property, Plant & Equipment (Net) (2010 - 2026)

Analysis

Ernexa Therapeutics (ERNAW) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Ernexa Therapeutics 67,312.70 67,312.70 - 82,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82,000.00
Mar 31, 2026 88,000.00
Dec 31, 2025 94,000.00
Sep 30, 2025 92,000.00
Jun 30, 2025 50,000.00
Mar 31, 2025 67,000.00
Dec 31, 2024 85,000.00
Sep 30, 2024 105,000.00
Jun 30, 2024 654,000.00
Mar 31, 2024 710,000.00
Dec 31, 2023 493,000.00
Sep 30, 2023 173,000.00
Jun 30, 2023 193,000.00
Mar 31, 2023 215,000.00
Dec 31, 2022 236,000.00
Sep 30, 2022 231,000.00
Jun 30, 2022 424,000.00
Mar 31, 2022 308,000.00
Dec 31, 2021 670,000.00
Sep 30, 2021 547,006.00